StockData
Cognition Therapeutics Inc logo

Cognition Therapeutics Inc (CGTX) stock

CGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.63−0.01 (-1.39%)

Close on Nov 17, 2026Market cap $59.90MP/E –Yield –

Cognition Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

No profit margin figures for Cognition Therapeutics

Cognition Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Cognition Therapeutics figures

See a number that looks wrong?